EndocrinologyPeer Reviewed
Cytologically non-malignant thyroid nodules with three or more high-risk genetic mutations have poor outcomes.
Authors (7)
Alexander R GoldbergHolman Division of Endocrinology, Diabetes, & Metabolism, Department of Medicine, NYU Grossman School of Medicine, New York, New York, USA.
Cheng LiuDepartment of Pathology, NYU Grossman School of Medicine, New York, New York, USA.
Gary D RothbergerHolman Division of Endocrinology, Diabetes, & Metabolism, Department of Medicine, NYU Grossman School of Medicine, New York, New York, USA.
Kepal N PatelDivision of Endocrine Surgery, Department of Surgery, NYU Grossman School of Medicine, New York, New York, USA.
Endocrine oncology (Bristol, England)
Unknown
Published
Oct 13, 2025
Abstract
Abstract not available - data parsing issue resolved
Keywords
EIF1AX mutationRAS mutationTERT mutationcytologythyroid cancerthyroid genetics
Article Metrics
Sourcepubmed
Related Research
Explore more articles in this research category to discover related studies and findings.
